| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acellular pertussis vaccines in infants: evaluation of single component and two-component products
|
Anderson, Edwin L.
|
|
1994
|
12 |
1 |
p. 28-31
4 p.
|
artikel
|
| 2 |
Calendar
|
|
|
1994
|
12 |
1 |
p. 93-
1 p.
|
artikel
|
| 3 |
Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit
|
Castello-Branco, Luiz R.R.
|
|
1994
|
12 |
1 |
p. 65-72
8 p.
|
artikel
|
| 4 |
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany
|
Heininger, Ulrich
|
|
1994
|
12 |
1 |
p. 81-86
6 p.
|
artikel
|
| 5 |
Do anaesthetics and surgical stress increase the risk of post-exposure rabies treatment failure?
|
Fescharek, R.
|
|
1994
|
12 |
1 |
p. 12-13
2 p.
|
artikel
|
| 6 |
Editorial
|
Russell, F.
|
|
1994
|
12 |
1 |
p. 3-
1 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
1994
|
12 |
1 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Expression of the merozoite surface protein gp195 in vaccinia virus
|
Sandhu, Jasbir Singh
|
|
1994
|
12 |
1 |
p. 56-64
9 p.
|
artikel
|
| 9 |
Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine
|
Elavia, A.J.
|
|
1994
|
12 |
1 |
p. 87-90
4 p.
|
artikel
|
| 10 |
Immunogenic hepatitis E virus peptides from the ORF1, ORF2 and ORF3 regions of hepatitis E virus — open reading frame-1, -2 and -3 recombinant peptide production; human recombinant monoclonal antibody production; useful as a recombinant vaccine
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 11 |
Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90–110 kDa) able to protect squirrel monkeys against asexual blood stages
|
Bonnefoy, Serge
|
|
1994
|
12 |
1 |
p. 32-40
9 p.
|
artikel
|
| 12 |
Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice
|
Romanova, Julia R.
|
|
1994
|
12 |
1 |
p. 23-27
5 p.
|
artikel
|
| 13 |
Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
|
Christenson, Brith
|
|
1994
|
12 |
1 |
p. 41-45
5 p.
|
artikel
|
| 14 |
Major histocompatibility complex II antigen; human major histocompatibility complex-II recombinant antigen expression in MRC-5 cell culture; potential recombinant vaccine against HIV virus-1 and HIV virus-2
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 15 |
Peritrophic membrane antigen from blowfly larva; prepared following tissue culture or cell culture; potential sheep recombinant vaccine to restrict or limit the effects of blowfly strike; DNA sequence
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 16 |
Potential of polymer microencapsulation technology for vaccine innovation
|
Morris, William
|
|
1994
|
12 |
1 |
p. 5-11
7 p.
|
artikel
|
| 17 |
Primary in vitro sensitization of human T-helper lymphocytes by peptides derived from the V3 loop of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein
|
Billaud, Jean Noël
|
|
1994
|
12 |
1 |
p. 46-55
10 p.
|
artikel
|
| 18 |
Production and in vivo use of recombinant ovine IL-1β as an immunological adjuvant
|
Andrews, A.E.
|
|
1994
|
12 |
1 |
p. 14-22
9 p.
|
artikel
|
| 19 |
Recombinant papillomavirus capsid protein; gene cloning in baculovirus vector for recombinant vaccine or diagnostic agent production in insect cell culture
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 20 |
Ryegrass pollen allergen; recombinant Lol pI expression in host cell, may be used for recombinant vaccine development or nuclear male sterile transgenic plant construction
|
|
|
1994
|
12 |
1 |
p. 92-
1 p.
|
artikel
|
| 21 |
Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells
|
Lipford, Grayson B.
|
|
1994
|
12 |
1 |
p. 73-80
8 p.
|
artikel
|
| 22 |
Vaccine against picornavirus, preferably cardiovirus; recombinant Mengovirus production with shortened poly(C) nucleotide tract; may be used as a recombinant vaccine
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 23 |
Vaccine against schistosomiasis; Schistosoma mansoni integral membrane protein antigen and TrpE fusion protein gene cloning an expression in Escherichia coli using a plasmid pATH vector for use as a recombinant vaccine
|
|
|
1994
|
12 |
1 |
p. 92-
1 p.
|
artikel
|
| 24 |
Vaccine comprising a T-lymphocyte receptor from T-cells which mediate a pathology; autoimmune disease e.g. multiple sclerosis and rheumatoid arthritis diagnosis, prevention, therapy, gene therapy and recombinant vaccine
|
|
|
1994
|
12 |
1 |
p. 91-
1 p.
|
artikel
|
| 25 |
Vaccine therapy for HIV: A historical review of the treatment of infectious diseases by active specific immunization with microbe-derived antigens
|
Burke, Donald S.
|
|
1994
|
12 |
1 |
p. 93-
1 p.
|
artikel
|
Tijdschrift beschrijving